Detalhe da pesquisa
1.
Synthesis and evaluation of inhibitors of cytochrome P450 3A (CYP3A) for pharmacokinetic enhancement of drugs.
Bioorg Med Chem Lett
; 19(18): 5444-8, 2009 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19679477
2.
Synthesis, antiviral activity, and conformational studies of a P3 aza-peptide analog of a potent macrocyclic tripeptide HCV protease inhibitor.
Bioorg Med Chem Lett
; 18(8): 2745-50, 2008 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18375121
3.
Degradation of high affinity HuD targets releases Kv1.1 mRNA from miR-129 repression by mTORC1.
J Cell Biol
; 202(1): 53-69, 2013 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23836929
4.
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
J Med Chem
; 52(10): 3174-83, 2009 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-19402666
5.
Synthesis, antiviral activity, and pharmacokinetic evaluation of P3 pyridylmethyl analogs of oximinoarylsulfonyl HIV-1 protease inhibitors.
Bioorg Med Chem
; 14(12): 4035-46, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16504523
6.
Synthesis and antiviral activity of P1' arylsulfonamide azacyclic urea HIV protease inhibitors.
Bioorg Med Chem Lett
; 14(15): 4075-8, 2004 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-15225729
7.
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitro.
Antimicrob Agents Chemother
; 48(6): 2260-6, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15155230